Werewolf Therapeutics Inc (HOWL) Directors and Executive Officers

Officers & Directors

Luke Evnin
Chair of the Board of Directors

Daniel J. Hicklin
President, Chief Executive Officer and Director (Principal Executive Officer)

Michael A. Sherman
Director

Alon Lazarus
Director

Derek DiRocco
Director

Meeta Chatterjee
Director

Michael B. Atkins
Director

Briggs W. Morrison
Director

Timothy W. Trost
Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) ,

Werewolf Therapeutics Inc currently has 39 employees.

News about Werewolf Therapeutics Inc Key Personnel

Werewolf Therapeutics Aims to Advance Clinical Assets with Strong 2024 Outlook

Werewolf Therapeutics Sets Strategic Outlook and Prioritizes Development of Clinical Assets
Werewolf Therapeutics, a leading biotechnology company, has recently provided a business update and outlined its strategic outlook for 2024. The company is focusing on the development of its two wholly owned clinical assets, WTX-124 and WTX-330, and anticipates key updates from both programs in the coming year.
According to Werewolf Therapeutics press release, the company has seen significant progress in the development of its INDUKINE™ programs. These programs, aimed at targeting the tumor microenvironment and enhancing anti-tumor immune responses, have shown promising results. The expected updates in 202...